References
- D. Bushinsky, J. Chabala, R. Levi‐Setti.(1989). Ion microprobe analysis of mouse calvariae in vitro: evidence for a “bone membrane” Am. J. Physiol 256:E152–E158.
- J. Fujisaki, Y. Tokunaga, T. Takahashi, T. Hirose, F. Shimojo, A. Kagayama, T. Hata.(1995). Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. I: synthesis and in vivo characterization of osteotropic carboxyfluorescein J. Drug Targeting 3:273–282.
- J. Fujisaki, Y. Tokunaga, T. Takahashi, S. Murata, F. Shimojo, T. Hata.(1996). Physicochemical characterization of bisphosphonic carboxyfluorescein for osteotropic drug delivery J. Pharm. Pharmacol.
- C. Hoggarth, R. Bennett, P. Daley‐Yates.(1991). The Pharmacokinetics and distribution of pamidronate for a range of dose in the mouse Calcif. Tissue Int. 49:416–420.
- C. Hunt, R. Macgregor, R. Siegel.(1986). Engineering targeted in vivo drug delivery. I. the physiological and physicochemical principles governing opportunities and limitations Pharm. Res. 3:333–344.
- A. Jung, S. Bisaz, H. Fleisch.(1973). The binding of pyrophosphonate and two diphosphonates by hydroxyapatite crystal Calc. Tiss. Res. 11:269–280.
- J. Lin, D. Duggan, I‐W. Chen, R. Ellsworth.(1991). Physiological disposition of alendronate, a potent antiosteolytic bisphosphonate, in laboratory animals Drug Metab. Dispos. 19:926–932.
- C. Metzler, G. Elfring, A. McEwen.(1974). A package of computer programs for pharmacokinetic modeling Biometrics 30:562–563.
- E. Ralston, L. Hjelmeland, R. Klausner, J. Weinstein, R. Blumenthal.(1981). Carboxyfluorescein as a probe for liposome‐cell interactions: effect of impurities, and purification of the dye Biochim. Biophys. Acta 649:133–137.
- V. Stella, K. Himmelstein.(1980). Prodrugs and site‐specific drug delivery J. Med. Chem. 23:1275–1282.
- A. Stevens, S. Martin, B. Brennan, M. Rowland, J. Houston.(1994). Experimental determination of a drug targeting index for S(+)ibuprofen using the rat air pouch model of inflammation J. Drug Targeting 2:333–339.
- R. Talmage.(1970). Morphological and physiological consideration in a new concept of calcium transport in bone Am. J. Anat. 129:467–476.
- E. Tomlinson.(1987). Theory and practice of site‐specific drug delivery Advanced Drug Delivery Reviews 1:87–198.
- F. Wingen, D. Schmähl.(1987). Pharmacokinetics of the osteotropic diphosphonate 3‐amino‐l‐hydroxypropane‐l,l‐diphosphonic acid in mammals Arzneim.‐Forsch./Drug Res. 37:1037–1042.
- N Bordor.M. Brewster.(1991). Handbook of Experimental Pharmacology Vol. 100, Targeted Drug Delivery231–284.
- H. Fleisch.(1988). Handbook of Experimental Pharmacology Vol. 83, Calcium in Drug Actions441–466.